TriplePoint Venture Growth BDC Corp. (TPVG)

9,53 -0,10 (-1,04%) Börsenschluss: 04:00PM EDT

TriplePoint Venture Growth BDC Corp.

2755 Sand Hill Road
Suite 150
Menlo Park, CA 94025
United States
650-854-2090
https://www.tpvg.com

Sektor(en): Financial Services
Branche: Asset Management
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. James Peter Labe	Co-Founder, Chairman & CEO	N/A	N/A	1957
Mr. Sajal K. Srivastava	Co-Founder, President, Chief Investment Officer, Secretary, Treasurer & Director	N/A	N/A	1976
Mr. Christopher M. Mathieu	Chief Financial Officer	N/A	N/A	1965
Mr. Alan Oshiki	Investor Relation - Abernathy MacGregor Group	N/A	N/A	N/A
Mr. Steven Mitchell Levinson	Chief Compliance Officer	N/A	N/A	1967

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.

Corporate Governance

TriplePoint Venture Growth BDC Corp.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.